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Incorporation of urea moiety in the synthesis of C-terminal neoglycopeptides has been
demonstrated through the reaction between suitably protected glycosylamine and Fmoc-
peptidyl isocyanates or carbamates. Curtius rearrangement has been made use oﬀ for the
conversion of peptidyl acid azides in to corresponding isocyanates. The resulting C-terminal
neoglycopeptidylureas have been isolated as stable solids which are fully characterized by 1H
NMR and mass spectroscopy.
KEY WORDS: Curtius rearrangement; neoglycopeptides; glycosylamine; ureido group; Fmoc-peptidyl
isocyanates.
INTRODUCTION
Synthesis of glycopeptides has received much
attention in recent years (Taylor, 1998; Kunz, 1987).
This is because the glycosylation of peptides modiﬁes
many of the biological properties of natural peptides
and hence enhances their biological and therapeutical
use. For instance, the glycosylation of natural peptide
has been shown e.g. to inﬂuence intercellular trans-
port of enzymes (Salvador et al., 1995) and protec-
tion against proteolysis. In an attempt to further
increase the utility of glycopeptides, a new class of
molecules called ‘‘neoglycopeptides’’ (Boons, 1998)
has been developed and is gaining much more syn-
thetic and therapeutical attention.
Neoglycopeptides, a class of modiﬁed glycopep-
tides containing a peptide segment linked to a car-
bohydrate through a non natural linkage are ﬁnding
increasing utility in recent years as alternative mole-
cules for their natural analogs as former have shown
to fulﬁll the carbohydrate requirement of the body
more eﬃciently. They can improve the absorption of
poorly bio-available drugs and peptides by enhancing
membrane transport (Kihlberg et al., 1995). Urea
moiety has become one of the fundamental func-
tionality for the replacement of peptide bond in
peptidomimetics (Castro et al., 1996). In medicinal
chemistry, urea bond has been used as critical struc-
tural element in enzyme inhibitors and potent analogs
of peptide drugs (Maya et al., 2003).
The urea moieties are known for their strong
hydrogen bonding capacity and this property is
expected to make the glycopeptidylureas more water
soluble than natural glycopeptides and hence acquire
wide utility in various biological functions. In one of
the earlier report for the synthesis of urea linked
neoglycopeptides (Ichikawa et al., 2006), a coupling
reaction was employed between glycosyl isocyanate
and peptidyl esters. Such protocols involve conver-
sion of glycosylamine to the corresponding isocya-
nate by the use of phosgene or triphosgene (Avalos
et al., 2006). In a diﬀerent approach, the preparation
of urea linked glycosylated amino acid derivatives of
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isoserine (Spengler et al., 2006) was carried out by the
reaction between glycosylamine and N-terminal
isocyanate of suitably protected isoserine (Bottcher
et al., 2003). These steps are synthetically less
attractive because they involve diﬃcult to handle
toxic reagents and give low yields. Here we describe a
simple and eﬃcient solution phase synthesis of
C-terminal neoglycopeptidylureas through the reac-
tion between protected glycosylamine and Fmoc
peptidylisocyanates.
MATERIALS AND METHODS
All solvents were freshly distilled before use.
Amino acids were used as received from Sigma-Al-
drich Company. Melting points were taken on a
Buchi model 150 melting point apparatus in open
capillaries. IR spectra were recorded on a Nicolet
model impact 400 D FT-IR spectrometer (KBr
pellets, 3 cm)1 resolution). 1H spectra were recorded
on a Bruker AMX 300 MHz spectrometer. High
resolution mass spectra (HR-MS) were recorded on
Q-Tof micromass mass spectrometer. Mass spectra
were also recorded on MALDI-TOF (KRATOS).
The Sonic bath is German make (35 KHz, Elma, T
310/H). The microwave reaction was carried out in a
LG MS 194 A microwave oven producing microwave
radiation with a frequency of 2450 MHz. The
microwave oven reaction was speciﬁcally carried out
at 60% of the total power output, which would
correspond to an average power of 720 W.
Synthesis of 2,3,4,6-tetra-O-acetyl-b-D-
glucopyranosyl azide
A solution of 2,3,4,6-tetra-O-acetyl-a-D-gluco-
pyranosyl bromide (0.4 g, 1 mmol) and sodium azide
(0.13 g, 2 mmol) in DMF (10 mL) was kept in soni-
cation for 15 min and the reaction was followed
through TLC. The reaction mixture was diluted with
water and extracted with ethyl acetate. The combined
organic layer was washed with water and brine. It
was dried over anhydrous sodium sulfate and con-
centrated under reduced pressure to get the desired
compound as white solid.
Synthesis of 2,3,4,6-tetra-O-acetyl-b-D-
glucopyranosyl amine
A solution of 2,3,4,6-tetra-O-acetyl-b-D-gluco-
pyranosyl azide (0.37 g, 1 mmol) in methanol was
stirred with Pd/C (37 mg, 10% wt.) under hydrogen
atmosphere at room temperature for 30 min. After
the completion of reaction (as indicated by TLC), the
reaction mixture was ﬁltered through celite bed and
washed with methanol. The ﬁltrate was concentrated
under reduced pressure to get the desired compound
as oﬀ white gummy solid.
The above three steps were repeated in similar
manner for other protected sugars as well.
Synthesis of Na-Fmoc-peptide isocyanates
Na-Fmoc-peptide acid (1 mmol) was dissolved in
dry THF (10 mL) and cooled in an ice salt bath.
N-methylmorpholine (NMM) (1.2 mmol) and ethyl
chloroformate (1.2 mmol) were added and the reac-
tion mixture was stirred for 20 min maintaining the
temperature at 0 C. Sodium azide (2 mmol) in water
(0.5 mL) was added and the reaction mixture was
stirred for another 30 min. THF was concentrated
and DCM (15 mL) was added. The organic layer was
washed with 10% citric acid solution (10 mL), 10%
sodium carbonate solution (15 mL), water and brine.
It was dried over sodium sulfate and concentrated.
The residue was taken in toluene (10 mL) and
exposed to microwave irradiation for 45 s. Toluene
was evaporated under reduced pressure and the
peptide isocyanate was isolated as a solid powder.
Fmoc-Leu-Phe-NCO
Yield = 86%. Mp 175 C. IR (KBr): 2246 cm)1.
1H NMR (CDCl3, 300 MHz): d 6.9–7.4 (m, 13H), 5.3
(m, 2H), 4.81–4.93 (m, 3H), 3.32 (m, 2H), 2.35–2.43
(m, 2H), 1.42 (m, 2H), 0.95 (d, 6H) ppm. HR-MS, m/z
calcd. for C30H31N3O4Na (M + Na) 520.5740,
found 520.5738.
Fmoc-Leu-Ala-NCO
Yield = 78%. Mp 178–180 C. IR (KBr):
2249 cm)1. 1H NMR (CDCl3, 300 MHz): d 7.3–7.85
(m, 8H), 6.59 (d, 1H), 5.33(d, 1H), 3.89–4.45 (m, 5H),
1.65 (m, 1H), 1.42 (m, 2H), 1.16 (d, 3H), 0.93 (d, 6H)
ppm. HR-MS, m/z calcd. for C24H27N3O4Na
(M + Na) 444.4781, found 444.4776.
Fmoc-Pro-Val-NCO
Yield = 75%. Mp 198 C. IR (KBr): 2251 cm)1.
1H NMR (CDCl3, 300 MHz): d 6.92–7.58 (m, 8H),
5.2 (d, 2H), 4.81–4.96 (m, 4H), 3.9 (m, 1H), 3.45
(s 1H), 2.6 (m, 4H), 1.8 (m, 3H), 1.38 (d, 6H) ppm.
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HR-MS, m/z calcd. for C25H27N3O4Na (M + Na)
456.4888, found 456.4852.
Fmoc-Phe-Leu-NCO
Yield = 82%. Mp 185 C. IR (KBr): 2256 cm)1.
1H NMR (CDCl3, 300 MHz): d 6.85–7.6 (m, 13H),
5.52 (m, 2H), 4.78–4.9 (m, 3H), 3.32 (m, 2H), 2.6 (m,
2H), 1.4 (m, 2H), 0.95 (d, 6H) ppm. HR-MS, m/z
calcd. for C30H31N3O4Na (M + Na) 520.5740,
found 520.5731.
Fmoc-Phe-Ala-Leu-NCO
Yield = 73%. Mp 188 C. IR (KBr): 2246 cm)1.
1H NMR (CDCl3, 300 MHz): d 7.23–7.86 (m, 13H),
6.58 (d, 1H), 5.32 (d, 1H), 4.92 (m, 3H), 3.8–4.45
(m, 4H), 2.4 (d, 2H), 1.65 (m, 1H), 1.45 (m, 2H),
1.15(d, 3H), 0.85 (d, 6H) ppm. HR-MS, m/z calcd. for
C33H36N4O5Na (M + Na) 591.6519, found
591.6532.
Fmoc-Val-Ile-Gly-NCO
Yield = 65%. Mp 135 C. IR (KBr): 2242 cm)1.
1H NMR (CDCl3, 300 MHz): d 7.2–7.78 (m, 8H),
5.34 (d, 1H), 4.83 (m, 4H), 3.56 (m, 4H), 1.95
(m, 2H), 1.7 (m, 2H), 1.32–1.4 (d, 12 H) ppm. HR-
MS, m/z calcd. for C28H34N4O5Na (M + Na)
529.5825, found 529.5830.
Fmoc-Cys(Bzl)-Phe-NCO
Yield = 75%. Mp 165 C. IR (KBr): 2252 cm)1.
1H NMR (CDCl3, 300 MHz): d 7.2–7.9 (m, 12H), 5.2
(m, 2H), 4.1 (m, 2H), 3.87 (m, 4H), 2.53(m, 4H), 1.63
(m, 1H), 1.4 (d, 2H) ppm. HR-MS, m/z calcd. for
C34H31N3O4SNa (M + Na) 600.6818, found
600.6828.
Fmoc-Phe-Ala-NCO
Yield = 83%. Mp 201 C. IR (KBr): 2248 cm)1.
1H NMR (CDCl3, 300 MHz): d 7.1–7.8 (m, 13H),
5.34 (d, 2H), 4.89–4.95 (m, 3H), 3.34 (m, 2H), 2.45(d,
2H), 1.16 (d, 3H) ppm. HR-MS, m/z calcd. for
C27H25N3O4Na (M + Na) 478.4943, found
478.4851.
Synthesis of Na-Fmoc-peptidyl active carbamate
2,4,5-Trichloro phenol (1.1 mmol) was added to
a solution of Fmoc-peptidyl isocyanate (1 mmol) in
dry DCM (10 mL) at 0 C followed by NMM
(1.5 mmol). It was allowed to warm to room tem-
perature and stirred for another 2 h. Hexane
(10 mL) was added and the precipitated compound
was ﬁltered, washed with hexane (15 mL) and dried
under suction to obtain the title compound as white
solids.
Fmoc-Leu-Ala-NH-CO-OTcp
Yield = 97%. Mp 166 C. IR (KBr): 1640 cm)1.
1H NMR (DMSO-d6, 300 MHz): d 7.3–7.85 (m, 10
H), 5.55 (d, 1H), 5.33 (d, 1H), 4.8 (m, 3H), 3.89–4.35
(m, 5H), 1.65 (m, 1H), 1.15 (d, 3H), 0.92 (d, 6H) ppm.
HR-MS, m/z calcd. for C30H30Cl3N3O5Na
(M + Na) 641.9245, found 641.9301.
Fmoc-Phe-Ala-NH-CO-OTcp
Yield = 96%. Mp 163 C. IR (KBr): 1642 cm)1.
1H NMR (DMSO-d6, 300 MHz): d 7.2–7.67(m, 15
H), 5.38 (d, 1H), 4.9 (m, 3H), 3.1–3.34(m, 4H), 1.53
(d, 2H), 1.23 (d, 3H) ppm. HR-MS, m/z calcd. for
C33H28Cl3N3O5Na (M + Na) 675.9407, found
675.9400.
Fmoc-Phe-Leu-NH-CO-OTcp
Yield = 96%. Mp 158 C. IR (KBr): 1642 cm)1.
1H NMR (DMSO-d6, 300 MHz): d 7.01–7.82 (m,
15H), 5.6 (d, 1H), 4.96(m, 3H), 3.9 (d, 2H), 3.1–3.3
(m, 3H), 1.58 (m, 3H), 1.41 (m, 1H), 0.89 (d, 6H)
ppm. HR-MS, m/z calcd. for C36H34Cl3N3O5Na
(M + Na) 718.0204, found 718.0195.
C-terminal Neoglycopeptidylureas
A solution of Na-Fmoc-peptidyl isocyanate or
Na-Fmoc-peptidyl carbamate (1 mmol) in dry DCM
(15 mL) was cooled in an ice bath and 2,3,4,6-tetra-
O-acetyl-glycosylamine (1 mmol) in dry DCM
(10 mL) was added. N-methylmorpholine (1 mmol)
was added and the reaction mixture was stirred at
same temperature for 2 h. After the completion of
reaction, the reaction mixture was washed with
10% citric acid solution (1 · 10 mL), water
(2 · 10 mL) and brine (2 · 10 mL). The organic
layer was dried over anhydrous sodium sulfate
and concentrated under reduced pressure. The
residue was recrystallised using ethyl acetate/hexane
to get the desired compound as white solid
(Table 2).
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Fmoc-Leu-Phe-NH-CO-NH-2,3,4,6-tetra-O-acetyl-
b-D-galactopyranoside
Yield = 78%. Mp 102 C. IR (KBr): 1652 cm)1.
1H NMR (DMSO-d6, 300 MHz): d 6.8–7.2(m, 13H),
5.63(m, 1H), 5.29(m, 3H), 5.12–5.25(m, 5H), 4.19(m,
1H), 3.92(d, 4H), 3.21(m, 2H), 2.93(d, 2H), 1.87–
1.93(s, 12H), 1.66(m, 2H), 1.57(m, 1H), 0.82(d, 6H)
ppm. HR-MS, m/z calcd. for C44H52N4O13Na
(M + Na) 867.8919, found 867.8942.
Fmoc-Leu-Ala-NH-CO-NH-2,3,4,6-tetra-O-acetyl-b-
D-glucopyranoside
Yield = 72%. Mp 164 C. IR (KBr): 1649 cm)1.
1H NMR (DMSO-d6, 300 MHz): d 6.92(m, 8H),
5.66(m, 1H), 5.17( m, 3H), 4.9–5.1(m, 5H), 4.31(m,
1H), 3.91(m, 4H), 3.27(m, 2H), 2.12(m, 1H), 1.77–
1.93(s, 12H), 1.38(m, 2H), 1.23(d, 3H), 0.93(m. 6H)
ppm. HR-MS, m/z calcd. for C38H48N4O13Na
(M + Na) 791.7959, found 791.7742.
Fmoc-Pro-Val-NH-CO-NH-2,3,4,6-tetra-O-benzoyl-
b-D-glucopyranoside
Yield = 70%. Mp 206 C. IR (KBr): 1651 cm)1.
1H NMR (DMSO-d6, 300 MHz): d 6.93–
7.3(m, 43H), 6.1(m, 1H), 5.07(m, 2H), 4.8–
5.03(m, 10H), 4.38(m, 1H), 4.17(m, 6H), 3.92(m, 2H),
1.83(m, 4H), 1.5(m, 2H), 1.43(m,1H), 0.87(d, 6H)
ppm. MALDI-TOFMS, m/z calcd. for C59H57N4O13
(M + H) 1030.1, found 1030.2.
Fmoc-Phe-Leu-NH-CO-NH-2,3,4,6-tetra-O-acetyl-b-
D-galactopyranoside
Yield = 76%. Mp 98 C. IR (KBr): 1650 cm)1.
1H NMR (DMSO-d6, 300 MHz): d 7.1–
7.32(m, 13H), 5.62(m, 1H), 5.43(m, 3H), 5.2(m, 5H),
4.21(m, 1H), 4.0(d, 4H), 3.4(m, 2H), 2.91(d, 2H),
1.83–1.98(s, 12H), 1.68(m, 2H), 1.61(m, 2H), 0.92(d,
6H) ppm. HR-MS, m/z calcd. for C44H52N4O13Na
(M + Na) 867.8919, found 867.8962.
Fmoc-Phe-Ala-Leu-NH-CO-NH-2,3,4,6-tetra-O-ben-
zoyl-b-D-glucopyranoside
Yield = 66%. Mp 212 C. IR (KBr): 1647 cm)1.
1H NMR (DMSO-d6, 300 MHz): d 7.4–8.13(m,
33H), 6.67(m, 2H), 5.21(s, 3H), 4.43(d, 2H), 4.13(m,
4H), 3.97(m, 5H), 2.94(d, 2H), 2.91(d, 2H), 1.37(d,
3H), 1.31(m.1H), 0.96(d, 6H) ppm. MALDI-TOF-
MS, m/z calcd. for C67H65N5O14Na (M + Na)
1187.2, found 1187.3.
Fmoc-Val-Ile-Gly-NH-CO-NH-2,3,4,6-tetra-O-ben-
zoyl-b-D-galactopyranoside
Yield = 67%. Mp 112 C. IR (KBr): 1643 cm)1.
1H NMR (DMSO-d6, 300 MHz): d 6.91–7.28(m,
28H), 6.1(m, 1H), 0.67(d, 6H), 5.21(m, 5H), 5.15
(m, 3H), 4.23(d, 2H), 4.13(m, 1H), 3.8(d, 2H), 3.53(m,
2H), 3.4(m, 2H), 1.73–1.81(m, 2H), 1.28(m, 2H),
0.94(m, 6H) ppm. MALDI-TOFMS, m/z calcd. for
C62H63N5O14Na (M + Na) 1125.17, found 1125.3.
Fmoc-Cys(Bzl)-Phe-NH-CO-NH-2,3,4,6-tetra-O-
acetyl-b-D-glucopyranoside
Yield = 75%. Mp 162 C. IR (KBr): 1656 cm)1.
1H NMR (DMSO-d6, 300 MHz): d 6.9–7.7(m, 18H),
5.8(m, 1H), 5.23(m, 5H), 5.13(m, 3H), 4.13(m, 1H),
4.01(d, 4H), 3.93(s, 2H), 3.82(m, 2H), 2.53(d, 2H), 1.91
(s, 12H) ppm. HR-MS, m/z calcd. for C48H52N4O13S-
Na (M + Na) 947.9997, found 947.9872.
Fmoc-Leu-Ala-NH-CO-NH-2,2¢,3,3¢,4¢,6,6¢-hepta-O-
acetyl-b-D-maltopyranoside
Yield = 69%. Mp 183 C. IR (KBr):1653 cm)1.
1H NMR (DMSO-d6, 300 MHz): d 6.9–7.1(m, 8H),
5.7(m, 1H), 5.3(m, 3H), 4.83–5.21(m, 10H), 4.23(m,
1H), 3.93(m, 6H), 3.22(m, 2H), 2.21(m, 1H), 1.86–
2.20(s, 21H), 1.37(m, 2H), 1.27(d, 3H), 0.92(m, 6H)
ppm. HR-MS, m/z calcd. for C50H64N4O21Na
(M + Na)1080.04, found 1080.5.
Fmoc-Phe-Ala- NH-CO-NH-2,2¢,3,3¢,4¢,6,6¢-hepta-O-
acetyl-b-D-maltopyranoside
Yield = 68%. Mp 189 C. IR (KBr):1652 cm)1.
1H NMR (DMSO-d6, 300 MHz): d 6.9–7.12(m,
13H), 6.02(m, 1H), 5.32(m, 3H), 4.91–5.12(m, 10H),
4.2(m, 1H), 3.8(d, 6H), 3.13(m, 2H), 2.4(d, 2H), 1.78–
2.12(s, 21H), 1.37(d, 3H) ppm. HR-MS, m/z calcd.
for C53H63N4O21 (M + H) 1091.8, found 1092.0.
RESULTS AND DISCUSSION
The hydroxyl groups of sugar moiety used were
protected either as acetyl or benzoyl esters using
acetic anhydride or benzoyl chloride in presence of
a base using a known procedure (Furniss et al.,
1989) (Scheme 1). The resulting protected glycosyl
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compounds were isolated as stable white solids. The
protecting group at C-1 of the glycosyl compound
was selectively replaced by bromine by the reaction
with HBr in acetic acid (Furniss et al., 1989). The
resulting 2,3,4,6-protected glycosyl bromide was used
in the next step directly. The conversion of bromo
compound to corresponding azide was carried out
under ultrasonication (Deng et al., 2006). For this, a
solution of glycosyl bromide (1 mmol) and sodium
azide (2 mmol) in DMF (10 mL) was kept in soni-
cation bath at ambient temperature. The reaction was
complete with in 15–20 min as detected by TLC and
the corresponding azide product was isolated as white
solid after work up. The azides showed a prominent
peak at around 2300 cm)1 in IR and can be stored at
room temperature for appreciable amount of time
without any decomposition (Table 1). Further, the
2,3,4,6-protected glycosyl azides were reduced to
corresponding amines by catalytic hydrogenation
using Pd/C (10% wt.) in methanol quantitatively
within 30 min. Almost similar steps were employed
with appropriate modiﬁcations for other saccharides
including disaccharide also.
Fmoc-peptide acids (Katritzky et al., 2006) were
prepared by the reaction of Fmoc-amino acid with
freshly prepared Bis-TMS-amino acid (Tantry et al.,
2002). They were converted to corresponding acid
azides via mixed anhydride. The Fmoc-peptidyl
azides were subjected to Curtius rearrangement to
furnish corresponding isocyanates (Patil et al., 2003;
Sureshbabu et al., 2006) by exposing the solution of
acid azide in toluene to microwave irradiation for
45 s (Scheme 2). All the peptidyl isocyanates were
isolated as stable crystalline solids that can be stored
under low temperature for long time.
For the preparation of neoglycopeptidylureas, the
protected glycosyl amine was reacted with Fmoc-
peptidyl isocyanate in presence of a base. In a typical
procedure, the glycosylamine (1.1 mmol) was added
to a stirred solution of Fmoc-peptidyl isocyanate
(1.0 mmol) in DCM at 0 C followed by N-meth-
ylmorpholine (1.2 mmol). The reaction was complete
with in 1.5–2 h which can be judged by TLC
(Scheme 2). The product was isolated as white solid
after work up and recrystallisation using hexane/ethyl
acetate (Table 2). This scheme is simple and eﬃcient
when compared to earlier method where the proce-
dure makes use of glycosyl isocyanate, the prepara-
tion of which needs handling of harmful reagents.
Further, the neoglycopeptidylureas were also
prepared employing Fmoc-peptidyl carbamates. The
active carbamates were prepared by the reaction of
Fmoc-peptidyl isocyanates with 2,4,5-trichloro phe-
nol (Scheme 3). These active carbamates react with
glycosylamines in the same way as Fmoc-peptidyl
isocyanates do. The added advantage is that these
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Scheme 2. Preparation of Fmoc peptide isocyanate and coupling
with glycosylamine to get C-terminal neoglycopeptidylurea.
Table 1. 1H NMR and HR-MS data of protected-b-D-sugar azides.
Sl.No Sugar azides 1H NMR data for 1-H anomeric proton b:a (%) HR-MS data
b-anomer
d ppm (JH-H¢, Hz)
a-anomer
d ppm (JH-H¢, Hz)
Calculated
(M + Na)+
Found
1 2,3,4,6-tetra-O-acetyl-b-D-galacto-
pyranosyl azide
5.21 (7.75) 5.68 (3.42) 98.47:1.53 396.3045 396.3038
2 2,3,4,6-tetra-O-acetyl-b-D-gluco-
pyranosyl azide
4.98 (6.53) 5.49 (2.73) 99.13:0.87 396.3045 396.3100
3 2,3,4,6-tetra-O-benzoyl-b-D-gluco-
pyranosyl azide
4.83 (6.89) 5.61 (3.06) 99.04:0.96 644.5821 644.5930
4 2,3,4,6-tetra-O-benzoyl-b-D-galac-
topyranosyl azide
5.01 (7.12) 5.72 (3.51) 98.36:1.64 644.5821 644.5912
5 2,2¢,3,3¢,4¢,6,6¢-hepta-O-acetyl-b-
D-maltopyranosyl azide
5.26 (8.01) 5.67 (3.13) 98.92:1.08 684.5552 684.5563
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Table 2. List of neoglycopeptidylurea.
Sl.No Neoglycopeptidylurea Method Time in h Yield % Melting Point
1
O
AcO
AcO
AcO OAc
H
N
H
N
H
N
O
NHFmoc
O
A 1.5 65 164
B 3.0 60
2 OAcO
AcO
OAc
H
N
H
N
H
N
O
NHFmoc
O
SBzAcO A 1.8 71 162
3
O
AcO
OAc
H
N
H
N
H
N
O
NHFmoc
O
AcO
AcO A 1.6 68 102
4
OAcO
OAc
H
N
H
N
H
N
O
NHFmoc
O
AcO
AcO
A 1.6 63 98
B 3.5 50
5
O
OBz
H
N
H
N
H
N
O
N
HO
BzO
BzO NHFmoc
OBzO A 1.4 60 212
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H
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H
N
H
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N
HO O
O
NHFmoc
A 1.8 58 112
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active carbamates have long shelf life and more stable
even at room temperature than corresponding pep-
tide isocyanates. These active carbamates when ad-
ded to a solution of glycosylamine in presence of a
base at lower temperature, reacted in almost same
rate as isocyanates with glycosylamines and the
products were isolated as pure white solids after work
up and recrystallisation (Scheme 3).
CONCLUSION
A simple and eﬃcient procedure for the synthesis
of C-terminal neoglycopeptidylureas in solution
phase has been demonstrated. The method makes use
of Curtius rearrangement for the conversion of Fmoc
peptide acid azide to corresponding isocyanate which
couples with protected glycosylamine to incorporate
a urea bond in between. The active carbamates pre-
pared by trapping the peptidyl isocyanates with tri-
chloro phenol were also employed for the synthesis of
neoglycopeptidylurea. All the neoglycopeptidylureas
have been isolated in good yield as stable white solids
which are fully characterized.
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Method-A: Using Peptide isocyanate, Method-B: Using active peptidylcarbamate.
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Scheme 3. Synthesis of 2,4,5 trichlorophenyl peptidyl carbamates
and their utilization for the synthesis of C-terminal neoglycopept-
idylureas.
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